Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Yeonsun | - |
dc.contributor.author | Sengupta, Sandip | - |
dc.contributor.author | Hur, Wooyoung | - |
dc.contributor.author | Sim, Taebo | - |
dc.date.accessioned | 2024-01-20T07:02:49Z | - |
dc.date.available | 2024-01-20T07:02:49Z | - |
dc.date.created | 2022-01-10 | - |
dc.date.issued | 2015-05-14 | - |
dc.identifier.issn | 0022-2623 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/125444 | - |
dc.description.abstract | We performed the first synthesis of the 17-carbon chain-tethered quinone moiety 22 (SAN5201) of irisferin A, a natural product exhibiting anticancer activity, and its derivatives. We found that 22 is a potent ROS inducer and cytotoxic agent. Compound 25 (SAN7401), the hydroquinone form of 22, induced a significant release of intracellular ROS and apoptosis (EC50 = 1.3-2.6 mu M) in cancer cell lines, including A549 and HCT-116. Compared with the activity of a well-known ROS inducer, piperlongumine, 22 and 25 showed stronger cytotoxicity and higher selectivity over noncancerous cells. Another hydroquinone tethering 12-carbon chain, 26 (SAN4601), generated reduced levels of ROS but showed more potent cytotoxicity (EC50 = 0.8-1.6 mu M) in cancer cells, although it lacked selectivity over noncancerous cells, implying that the naturally occurring 17-carbon chain is also crucial for ROS production and a selective anticancer effect. Both 25 and 26 displayed strong, equipotent activities against vemurafenib-resistant SK-Mel2 melanoma cells and p53-deficient H1299 lung cancer cells as well, demonstrating their broad therapeutic potential as anticancer agents. | - |
dc.language | English | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.subject | CANCER-CELLS | - |
dc.subject | OXIDATIVE STRESS | - |
dc.subject | APOPTOSIS | - |
dc.subject | ACTIVATION | - |
dc.subject | MECHANISM | - |
dc.subject | AKT | - |
dc.subject | VEMURAFENIB | - |
dc.title | Identification of Novel ROS Inducers: Quinone Derivatives Tethered to Long Hydrocarbon Chains | - |
dc.type | Article | - |
dc.identifier.doi | 10.1021/jm501846y | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | JOURNAL OF MEDICINAL CHEMISTRY, v.58, no.9, pp.3739 - 3750 | - |
dc.citation.title | JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.volume | 58 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 3739 | - |
dc.citation.endPage | 3750 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000354911200007 | - |
dc.identifier.scopusid | 2-s2.0-84929485472 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | CANCER-CELLS | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | MECHANISM | - |
dc.subject.keywordPlus | AKT | - |
dc.subject.keywordPlus | VEMURAFENIB | - |
dc.subject.keywordAuthor | ROS | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.